Current Report Filing (8-k)
August 15 2016 - 4:21PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 15, 2016
IMMUDYNE,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
333-184487
|
|
76-0238453
|
(State
or other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification No.)
|
50
Spring Meadow Rd.
Mount
Kisco, NY
|
|
10549
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
(914) 244-1777
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
2.02. Results of Operations and Financial Condition.
On
August 15, 2016, Immudyne, Inc. (the “Company”) issued a press release announcing the Company’s financial
results for the three and six months ended June 30, 2016, a copy of which is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
The
earnings press release furnished herewith contains financial measures that are not in accordance with generally accepted accounting
principles in the United States of America (“
GAAP
”). For purposes of Regulation G, a non-GAAP financial measure
is a numerical measure of a company’s historical or future financial performance, financial position or cash flows that
excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly
comparable measure calculated in accordance with GAAP in the statements of operations, balance sheets, or statements of cash flows
of the company; or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded
from the most directly comparable measure so calculated and presented. Pursuant to the requirements of Regulation G, the Company
has provided reconciliations within the earnings release of the non-GAAP financial measures to the most directly comparable GAAP
financial measures. The non-GAAP financial measures described above should be considered in addition to, but not as a substitute
for, measures of financial performance prepared in accordance with GAAP that are presented in the earnings release.
The
information in this Item 2.02 of this Form 8-K shall not be deemed to be “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item
9.01. Financial Statements and Exhibits
99.1
|
Press
Release of Immudyne, Inc., dated August 15, 2016, with respect to the Company’s financial results for the three
and six months ended June 30, 2016 (furnished only).
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
IMMUDYNE
INC.
|
|
(Registrant)
|
|
|
Date:
August 15, 2016
|
By:
|
/s/
Mark McLaughlin
|
|
Name:
|
Mark
McLaughlin
|
|
Title:
|
Chief
Executive Officer
|
3